申请人:——
公开号:US20030220356A1
公开(公告)日:2003-11-27
The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for treating coronary artery disease.
本发明提供了一种能够提高ABCA-1基因细胞表达的化合物,促进胆固醇从细胞中流出并增加哺乳动物(尤其是人类)血浆中的高密度脂蛋白水平。这些化合物可用于治疗冠心病。